1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Israel Pharmaceuticals and Healthcare Report Q4 2016

Israel Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 113 pages

Includes 3 FREE quarterly updates

BMI View:

Israel will continue to be targeted by multinational drugmakers as a destination for innovative drug sales; however, their relative success will be limited by funding constraints towards the country's health services basket and the lack of transparency with new drug inclusions. An uptick in economic growth and an increase to government funding supports our moderate growth outlook for Israel's pharmaceuticals and healthcare sectors over the coming years.

Headline Expenditure Projections


- Pharmaceuticals: ILS7.82bn (USD2.01bn) in 2015 to ILS8.15bn (USD2.11bn) in 2016; +4.2% in local currency terms and +4.6% in US dollar terms. Forecast in line with Q316.

- Healthcare: ILS88.95bn (USD22.90bn) in 2015 to ILS93.61bn (USD24.19bn) in 2016; +5.2% in local currency terms and +5.6% in US dollar terms. Forecast downgraded from Q316.

Table Of Contents

Israel Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Israel 2014-2020) 7
SWOT Analysis 9
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Israel 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Israel 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Israel 2014-2020) 32
Industry Risk/Reward Index 33
Middle East and Africa Risk/Reward Index - Q4 2016 33
Israel Risk/Reward Index 41
Rewards 41
Risks 41
Regulatory Review 43
Intellectual Property Issues 45
Pricing Regime 49
Table: Price Build-Up In The Israeli Pharmaceutical Market 50
Reimbursement Regime 50
Market Overview 55
Healthcare Sector 55
Table: Healthcare Resources (Israel 2010-2015) 62
Table: Healthcare Personnel (Israel 2010-2015) 62
Table: Healthcare Activity (Israel 2010-2015) 63
Research and Development 63
Table: Israel's RandD Legislation - Conditions For OCS Funding 66
Clinical Trials 66
Epidemiology 70
Competitive Landscape 73
Research-Based Industry 73
Table: Multinational Pharmaceutical Company Activity 76
Pharmaceutical Distribution 77
Pharmaceutical Retail Sector 77
Company Profile 79
Dexcel Pharma 79
Neopharm Group 82
Perrigo (Agis Industries) 85
Taro Pharmaceutical Industries 89
Teva Pharmaceutical Industries 93
Demographic Forecast 102
Table: Population Headline Indicators (Israel 1990-2025) 103
Table: Key Population Ratios (Israel 1990-2025) 104
Table: Urban/Rural Population and Life Expectancy (Israel 1990-2025) 104
Table: Population By Age Group (Israel 1990-2025) 105
Table: Population By Age Group % (Israel 1990-2025) 106
Glossary 107
Methodology 109
Pharmaceutical Expenditure Forecast Model 109
Healthcare Expenditure Forecast Model 109
Notes On Methodology 110
Risk/Reward Index Methodology 111
Index Overview 112
Table: Pharmaceutical Risk/Reward Index Indicators 112
Indicator Weightings 113

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.